[Preliminary Study on Antibacterial Activity of Recombinant Fusion Protein Pheromonicin-PA to Pseudomonas Aeruginosa in Vitro/in Vivo].

Liang Sun,Jie Zhang,Ping Dai,Yan Qin,Xiao-Qing Qiu
DOI: https://doi.org/10.3969/j.issn.1672-173x.2006.06.002
2006-01-01
Abstract:OBJECTIVE:To prepare the engineering peptide Pheromonicin-P. aeruginosa (Ph-PA) and evaluate the antibactericidal activity of prepared Ph-PA against P. aeruginosa via in vitro/in vivo bactericidal assays.METHODS:Ph-PA was purified by CM sepharose ion-exchange column. In vitro/in vivo bactericidal assays were performed to identify the antibactericidal activity of Ph-PA against P. aeruginosa.RESULTS:In vitro and in vivo data showed that antibactericidal effects of Ph-PA, on molar basis, were approximately over 2200 times greater than that of piperacillin, and 220 times greater than that of ceftazidime against P. aeruginosa.CONCLUSION:The Ph-PA may have potentially applied value as a novel kind of peptide antibiotics against P. aeruginosa infection.
What problem does this paper attempt to address?